ANL: Rounding Bottom detected on 9 Apr 2026
All prices, scores, and news on this page reflect data available before market open on .
Overall Score
78
of 100
Good
Win Probability
64%
Moderate
Reward / Risk
0.3
: 1
$0.09 reward
$-0.34 risk
Current Setup
ANL is forming a rounding bottom pattern with a structure score of 13.75/15, indicating solid foundational setup quality. The stock is consolidating near $12.03, sandwiched between key support at $0.88 and resistance at $1.55 (note: likely chart-pattern-specific intermediate levels). Breakout score of 13.0/13 and volume score of 12.0/12 signal strong technical confirmation—current volume of 1.34M shares represents 4.54x the 20-day average, showing institutional accumulation. Overall pattern quality score of 77.75/98 reflects a compelling technical setup with high pattern conviction.
Stock Context
On February 3, 2026, ANL announced a $140 million private placement equity financing with gross proceeds. The company sold 64.6M Class A shares (21.5M ADSs) at $6.50 per ADS, with CEO Yang Lu's entities purchasing approximately $55 million of shares, signaling leadership confidence. On February 12, 2026, ANL announced first patient dosing in its Phase 1 trial of AN9025, a pan-RAS inhibitor. Leerink initiated ANL with Outperform on March 20, 2026, and analyst price target is $16.00. The stock has surged dramatically—up 723.97% over three months and 73.84% in one week alone—driven by clinical momentum, capital raise validation, and bullish sector sentiment (regime score 0.62).
What to Expect
A successful breakout above resistance at $1.55 would target $12.83 (conservative measured move), reflecting 6.6% upside from current $12.03. Breakout confirmation requires volume sustaining at 4.5x+ average, a technical hallmark of institutional conviction. The pattern invalidates decisively below support at $0.88—a move to that level would signal consolidation failure and reverse the bullish thesis. Win probability of 64.22% suggests better-than-coin-flip odds, though rounding bottoms historically deliver best results on 2-3 month timeframes. Breakout would likely accelerate through 20-day Bollinger Band upper of ~13.5.
Risk Factors
ANL is scheduled to report earnings February 25, 2026—near-term volatility catalyst given clinical-stage status. RSI of 78.15 signals overt overbought territory (>70 threshold), creating pullback risk despite strong trend. High recent gains (723% in 3 months) reflect euphoric sentiment vulnerable to profit-taking. Volatility at 119% annualized is elevated; beta of 0.51 provides some downside cushion but limits upside capture if market sells off. ANL has lost over $130 million in just over two years as a clinical-stage company with no marketed products. Regulatory risk remains material—Phase 3 BURAN trial (AN2025) and early-stage programs could face trial delays or safety signals. Further dilution from registered resale of private placement shares poses overhang.
Sources:
Adlai Nortye Ltd. (ANL) Stock Price, News, Quote & History - Yahoo Finance
·
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
·
News Releases | Adlai Nortye Limited
·
Latest ANL News - Adlai Nortye Announces First Patient Enrolle...
·
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations | Adlai Nortye Limited
·
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
·
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
·
ANL: Adlai Nortye Ltd - Stock Price, Quote and News - CNBC
·
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing | | caledonianrecord.com
·
Adlai Nortye raises $140M in private placement | ANL SEC Filing - Form 6-K
·
Adlai Nortye Ltd. (ANL) Stock Price, News, Quote & History - Yahoo Finance
·
Adlai Nortye (ANL) Stock Price & Overview
·
Check out Adlai Nortye Ltd's stock price (ANL) in real time
·
Stock Quote & Chart - Investor Relations | Adlai Nortye Limited
·
Adlai Nortye Ltd. American Depositary Shares (ANL) Stock Price, News, Quotes, & Historic Data | Nasdaq
·
Adlai Nortye (Nasdaq:ANL) - Stock Analysis - Simply Wall St
·
ANL: Adlai Nortye Ltd Stock Price Quote - NASDAQ GM - Bloomberg
·
ANL - Stock Quotes for Adlai Nortye Ltd. - Webull
·
ANL - Adlai Nortye Ltd. ADR Stock Price and Quote
·
Adlai Nortye Ltd ADR Stock Price Today | NASDAQ: ANL Live - Investing.com
Market & Sector Regime
Market
Bullish
0.87
-1.0
0
+1.0
Health Care Sector
Bullish
0.62
-1.0
0
+1.0
Overall Score
39
of 40
Pattern Quality
20
of 20
Setup
11
of 20
R/R
8
of 18
Context
Pattern Quality Score
14
of 15
Structure
13
of 13
Breakout
12
of 12
Volume
Recent Performance
Momentum & Trend
RSI (14)
78.2
Overbought
MACD Histogram
+0.37
Bullish
Bollinger Band Position
129.3%
Upper Band
Volatility & Risk
20-Day Volatility
1.19
Very High
ATR %
8.7%
High
Beta
0.51
Below Mkt
Volume Analysis
Volume Ratio
4.54x
Very High
20-Day Avg Vol
296K
shares / day
Current Volume
1.3M
shares traded
Price Levels
Target
$12.83
52W High
$12.15
Current
$12.03
Stop Loss
$10.94
Resistance
$1.55
Support
$0.88
52W Low
$0.88
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.